Beit Jala Pharmaceutical Company reported unaudited earnings results for the nine months ended September 30, 2018. For the period, the company reported sales of JOD 5,106,829 against JOD 5,866,579 a year ago. Net Income before tax was JOD 660,942 against JOD 1,025,605 a year ago. Net Income after tax was JOD 611,371 against JOD 948,685 a year ago. Basic and diluted earnings per share were JOD 0.087 against JOD 0.136 a year ago.